$RDVT

Red Violet (NASDAQ:RDVT) Insider Jeffrey Alan Dell Sells 10,000 Shares

Red Violet (NASDAQ:RDVT) insider Jeffrey Alan Dell sold 10,000 shares on June 1 at an average $57.44, totaling $574,400, according to an SEC filing. After the sale, he directly owned 155,889 shares (~$8.95M). The stock traded around $59.30 midday. In its May 6 quarter, RDVT reported $0.46 EPS and $25.83M revenue.

Original reporting
Published Jun 2, 2026, 1:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 2:19 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Red Violet (NASDAQ:RDVT) Insider Jeffrey Alan Dell Sells 10,000 Shares — source image
Decision brief

The 30-second read

$RDVTNeutralLow
01

Why it matters

This is primarily a sentiment/positioning datapoint. Without new guidance, contract, or regulatory developments, it is unlikely to materially reprice the company by itself.

02

Market read

Traders may monitor RDVT for follow-through in sentiment, but the actionable driver remains the company’s recent earnings/analyst stance rather than this transaction alone.

03

What to watch

The piece also notes recent earnings beat and multiple analyst downgrades to Hold; traders may weigh those fundamentals more than the single insider sale.

Relevance 6/10Novelty 6/10Timing: Today/this week: SEC Form 4 insider sale disclosed for June 1 transaction.

Background

The article is an SEC-disclosed insider transaction (Form 4) tied to Red Violet’s stock performance and recent earnings/analyst commentary.

Company-level read

Ticker impact

$RDVTNeutralMedium confidence
Context

Red Violet insider Jeffrey Alan Dell sold 10,000 shares at an average $57.44, reducing his stake by 6.03% per SEC filing.

Expected impact

Likely limited/short-lived impact; any move would be dominated by broader earnings/analyst sentiment rather than this single sale.

Evidence & confidence

The disclosure is time-stamped (June 1 sale) and ownership decreased, but there is no accompanying guidance change, deal, or regulatory event.

Market effects

Minor read-through for fintech/financial-crime analytics names: insider selling can modestly affect sentiment around governance/valuation, but no sector-wide shock is indicated.

Primarily US small/mid-cap sentiment; no cross-region linkage described.

Limited global relevance; the event is company-specific insider activity.

Counterpoint

Insider sales can be routine (taxes/diversification) and may not reflect negative expectations; the article doesn’t state motive or whether it was pre-planned under a trading plan.

Key entities

  • Red Violet, Inc.

    NASDAQ-listed provider of data/analytics solutions for financial crime, fraud and security risk; subject of the insider sale disclosure.

  • Jeffrey Alan Dell

    Insider who sold 10,000 RDVT shares at $57.44 average price on June 1, reducing ownership by 6.03%.

Related articles

$RDVTMedAI 8/10

red violet Announces Closing of $115 Million Underwritten Public Offering of Common Stock, Including Full Exercise of Underwriters' Option

Red Violet, Inc. (NASDAQ: RDVT) said it closed an underwritten public offering of 1,916,667 shares of common stock, including 250,000 shares from full exercise of the underwriters’ option. The company estimates net proceeds of about $108.6 million. Proceeds will be used for working capital, general corporate purposes, and potential strategic acquisitions.

$RDVTMedAI 8/10

red violet Announces Pricing of $100 Million Underwritten Public Offering of Common Stock

Red Violet, Inc. (NASDAQ: RDVT) priced an underwritten public offering of 1,666,667 shares of common stock at $60.00 per share, raising expected gross proceeds of $100 million before underwriting fees and expenses. The offering is expected to close Aug. 7, 2026, with a 30-day option for up to 250,000 additional shares. Net proceeds will fund working capital and corporate purposes.

$RKLBMedAI 8/10

Rocket Lab Just Unveiled a Game-Changing Technology Worth Watching

Rocket Lab (RKLB) said it won a $397 million U.S. Space Force contract to develop, launch, and operate multiple Flatellites for the SB-AMTI program. Flatellites are slimmer, stackable satellites intended to increase deployments per launch and integrate with Rocket Lab’s Neutron rocket. The article cites analyst forecasts for revenue rising from $602M (2025) to $1.7B (2028).

$AVAVMedAI 8/10

Bloomberg: US to purchase anti-drone lasers for $400 million

Bloomberg reports the Pentagon will buy laser-based counter-drone systems from AeroVironment Inc. in a deal valued at at least $400 million. The contract is expected to supply the Army with dozens of Locust systems, described as an AI-enabled laser system for tracking and disabling small and medium UAVs. AeroVironment shares rose 8.1% intraday, according to the report.